Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Novartis India LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500672NSE Symbol: NOVARTINDP/E(TTM):46.33
ISIN Demat:INE234A01025Div & Yield %:1.36EPS(TTM):39.6
Book Value(Rs):331.2308625Market Cap (rupee Cr.):4530.14Face Value(Rs):5
    
(rupee In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 376.96390.09366.84413.52486.66453.73
Excise Duty0.000.000.000.000.000.00
Net Sales376.96390.09366.84413.52486.66453.73
Other Income 38.7741.9661.6858.1133.1933.09
Stock Adjustments 12.21-3.75-9.86-2.359.12-10.74
Total Income427.94428.30418.66469.28528.97476.08
EXPENDITURE :      
Raw Materials 210.58199.07189.98199.34187.26135.88
Power & Fuel Cost0.110.140.180.350.530.53
Employee Cost 21.0818.7222.9635.64101.89108.51
Other Manufacturing Expenses 9.598.185.0012.5831.1533.51
Selling and Administration Expenses 47.3959.7465.5582.78144.40128.11
Miscellaneous Expenses 6.329.078.0515.4053.089.66
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure295.07294.92291.72346.09518.31416.20
Operating Profit132.87133.38126.94123.1910.6659.88
Interest 1.260.771.491.754.837.68
Gross Profit131.61132.61125.45121.445.8352.20
Depreciation1.952.192.616.069.6512.16
Profit Before Tax129.66130.42122.84115.38-3.8240.04
Tax34.9529.9637.631.68-0.4422.62
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.53-0.440.0210.340.34-3.48
Reported Net Profit93.18100.9085.19103.36-3.7220.90
Extraordinary Items -0.020.141.990.17-44.680.03
Adjusted Net Profit93.20100.7683.20103.1940.9620.87
Adjst. below Net Profit 1.420.971.213.118.19-6.09
P & L Balance brought forward768.98728.84759.72677.94698.16708.04
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 61.7361.73117.2824.6924.6924.69
P & L Balance carried down801.85768.98728.84759.72677.94698.16
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %500.00500.00500.00950.00200.00200.00
Earnings Per Share-Unit Curr37.7640.8834.5241.88-1.518.47
Earnings Per Share(Adj)-Unit Curr37.7640.8834.5241.88-1.518.47
Book Value-Unit Curr331.37318.06301.79314.29280.27288.16